ondansetron has been researched along with Intraventricular Septal Defects in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Literature is divided regarding the risk of neonatal ventricular septal defect (VSD) associated with first trimester ondansetron use in pregnancy." | 7.96 | Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect. ( Bodnar, LM; Caritis, SN; Garrard, W; Lemon, LS; Marroquin, OC; Platt, RW; Venkataramanan, R, 2020) |
| "Literature is divided regarding the risk of neonatal ventricular septal defect (VSD) associated with first trimester ondansetron use in pregnancy." | 3.96 | Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect. ( Bodnar, LM; Caritis, SN; Garrard, W; Lemon, LS; Marroquin, OC; Platt, RW; Venkataramanan, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lemon, LS | 1 |
| Bodnar, LM | 1 |
| Garrard, W | 1 |
| Venkataramanan, R | 1 |
| Platt, RW | 1 |
| Marroquin, OC | 1 |
| Caritis, SN | 1 |
1 other study available for ondansetron and Intraventricular Septal Defects
| Article | Year |
|---|---|
Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect.
Topics: Female; Heart Septal Defects, Ventricular; Humans; Infant, Newborn; Ondansetron; Pregnancy; Pregnanc | 2020 |